< Back to scientific publications

Magazine 9.54

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First ItalianųoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Irelli EC, Chiesa V, Dainese F, De Maria G, Didato G, Gennaro GD, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership

Date: 2022

Scope of interest: Epilepsy




You may also be interested in:

Magazine 11.50

Cryptogenic focal epilepsy and “hidden” celiac disease in adulthood: a causal or accidental link?

Authors: Casciato S, Morano A, Albini M, Fanella M, Lapenta L, Fattouch J, Carnì M, Colonnese C, Manfredi M, Giallonardo AT, Di Bonaventura C

Date: 2015

Scope of interest: Epilepsy


Read details
Magazine 8.37

Epilepsy, unawareness of seizures and driving license: the potential role of 24-hour ambulatory EEG in defining seizure freedom.

Authors: Fattouch J, Di Bonaventura C, Lapenta L, Casciato S, Fanella M, Morano A, Manfredi M, Giallonardo AT

Date: 2012

Scope of interest: Epilepsy


Read details
Report/Poster of Convention/Congress Act

Strict glycemic control is associated with a loss in ADLs in elderly diabetic patients admitted to RSA: Results of the DIMORA STUDY

Authors: Armellini F., Bo M., D’Amico F., Desideri G., Falaschi P., Greco A., Guerrini G., Lattanzio F., Volpe C., Abbatecola A.M., Paolisso G

Date: 2014

Scope of interest: RSA, diabetes


Read details